Optimizing identification and management of COPD patients – reviewing the role of the community pharmacist

Abstract

The aim of this paper was to propose key steps for community pharmacist integration into a patient care pathway for chronic obstructive pulmonary disease (COPD) management. A literature search was conducted to identify publications focusing on the role of the community pharmacist in identification and management of COPD. The literature search highlighted evidence supporting an important role for pharmacists at each of the four key steps in the patient care pathway for COPD management. Step 1 (primary prevention): pharmacists are ideally placed to provide information on disease awareness and risk prevention campaigns, and to encourage lifestyle interventions, including smoking cessation. Step 2 (early detection/case finding): pharmacists are often the first point of contact between the patient and the healthcare system and can therefore play an important role in the early identification of patients with COPD. Step 3 (management and ongoing support): pharmacists can assist patients by providing advice and education on dosage, inhaler technique, treatment expectations and the importance of adherence, and by supporting self‐management, including recognition and treatment of COPD exacerbations. Step 4 (review and follow‐up): pharmacists can play an important role in monitoring adherence and ongoing inhaler technique in patients with COPD. In summary, pharmacists are ideally positioned to play a vital role in all key stages of an integrated COPD patient care pathway from early disease detection to the support of management plans, including advice and counselling regarding medications, inhaler technique and treatment adherence. Areas requiring additional consideration include pharmacist training, increasing awareness of the pharmacist role, administration and reimbursement, and increasing physician–pharmacist collaboration.

<p>The Potential Role of the Pharmacist in Supporting Patients with Depression – A Literature-Based Point of View</p>

“…The pharmacist's obligations in the process of providing pharmaceutical care are: (1) collection of specific information for the patient's demographic data, history of disease, medication therapy (current therapy, dose, therapeutic regimen, allergies, immunizations, previous drug therapy), current complaints; (2) analyzing the collected information so as to identify drug-related problems, to assess whether all medications are effective and safe for the patient as well as patient's adherence and compliance. 33,34 Follow-up was aimed at defining the therapy effectiveness and long-term safety,…”

How to design an education programme for patients with chronic obstructive disease?

“…In order to keep up with this spirit and to build the educators' reputation in the project, we identified the following key benefits of employing a pharmacist in the project, along with [19]: 1. primary prevention: campaigns, lifestyle counseling, awareness raising; 2. early diagnosis; 3. management and ongoing support: pharmacist care, information on inhalation device use, disease outlook, dosage, self-management of the disease; 4. overview and follow-up: monitoring adherence and device use. This connects to the content of the community pharmacy pillar of our education, and we considered these points to define the potential role of the pharmacist in our education project.…”

What factors influence an early COPD diagnosis in primary care?

“…Community pharmacists are ideally placed to identify patients with COPD through early case-finding. Pharmacists are regularly the first port-of-call for patients expressing signs of COPD such as breathlessness or risk factors such as smoking, and are able to screen patients at risk (van der Molen et al, 2017).…”